Candidemia and invasive candidiasis in the adult: Clinical forms and treatment;Candidemia y candidiasis invasora en el adulto. Formas clínicas y tratamiento

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 30, Issue 8, 2012, Pages 483-491

  Cervera, Carlos ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Anti fungal; Candidemia; Invasive candidiasis; Treatment

Indexed keywords

ANTIFUNGAL AGENT;

ARTICLE; CANDIDEMIA; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL FEATURE; COST BENEFIT ANALYSIS; ESOPHAGITIS; HEALTH CARE COST; HUMAN; INVASIVE CANDIDIASIS; PERITONITIS; PRACTICE GUIDELINE; URINARY TRACT INFECTION;

ADULT; ANTIFUNGAL AGENTS; CANDIDEMIA; CANDIDIASIS, INVASIVE; COST-BENEFIT ANALYSIS; DISEASE MANAGEMENT; FEMALE; HUMANS; MALE; NEUTROPENIA; ORGAN SPECIFICITY; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSTHESIS-RELATED INFECTIONS; SPECIES SPECIFICITY;

EID: 84866737077     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2012.02.003     Document Type: Article

References (60)

1. M.R. Ananda-Rajah, A. Cheng, C.O. Morrissey, T. Spelman, M. Dooley, and A.M. Neville Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach Antimicrob Agents Chemother 55 2011 1953 1960
2. P.G. Pappas, C.A. Kauffman, D. Andes, D.K. Benjamin Jr., T.F. Calandra, and J.E. Edwards Jr. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America Clin Infect Dis 48 2009 503 535
3. B.J. Kullberg, P.E. Verweij, M. Akova, M.C. Arendrup, J. Bille, and T. Calandra European expert opinion on the management of invasive candidiasis in adults Clin Microbiol Infect 17 Suppl 5 2011 1 12
4. J.M. Aguado, I. Ruiz-Camps, P. Munoz, J. Mensa, B. Almirante, and L. Vazquez Recomendaciones sobre el tratamiento de la candidiasis invasiva y otras infecciones por levaduras de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Actualización 2011 Enferm Infecc Microbiol Clin 29 2011 345 361
5. G.S. Martin, D.M. Mannino, S. Eaton, and M. Moss The epidemiology of sepsis in the United States from 1979 through 2000 N Engl J Med 348 2003 1546 1554
6. M.A. Pfaller, and D.J. Diekema Epidemiology of invasive candidiasis: a persistent public health problem Clin Microbiol Rev 20 2007 133 163
7. B. Almirante, D. Rodriguez, B.J. Park, M. Cuenca-Estrella, A.M. Planes, and M. Almela Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003 J Clin Microbiol 43 2005 1829 1835
8. K.W. Garey, M. Rege, M.P. Pai, D.E. Mingo, K.J. Suda, and R.S. Turpin Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study Clin Infect Dis 43 2006 25 31
9. M. Morrell, V.J. Fraser, and M.H. Kollef Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality Antimicrob Agents Chemother 49 2005 3640 3645
10. M.H. Nguyen, J.E. Peacock Jr., D.C. Tanner, A.J. Morris, M.L. Nguyen, and D.R. Snydman Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study Arch Intern Med 155 1995 2429 2435
11. J.H. Rex, J.E. Bennett, A.M. Sugar, P.G. Pappas, J. Serody, and J.E. Edwards Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group Clin Infect Dis 21 1995 994 996
12. R. Luzzati, G. Amalfitano, L. Lazzarini, F. Soldani, S. Bellino, and M. Solbiati Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital Eur J Clin Microbiol Infect Dis 19 2000 602 607
13. M. Nucci, E. Anaissie, R.F. Betts, B.F. Dupont, C. Wu, and D.N. Buell Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials Clin Infect Dis 51 2010 295 303
14. D.L. Horn, L. Ostrosky-Zeichner, M.I. Morris, A.J. Ullmann, C. Wu, and D.N. Buell Factors related to survival and treatment success in invasive candidiasis or candidemia: a pooled analysis of two large, prospective, micafungin trials Eur J Clin Microbiol Infect Dis 29 2010 223 229
15. G.C. Koh, and M.L. Luong Early removal of central venous catheters and outcomes from candidemia Clin Infect Dis 51 2010 1347 author reply 8-50
16. H. Shaked, M. Paul, and J. Bishara Catheter extraction does not improve survival in candidemia, or does it? Clin Infect Dis 51 2010 1347 1348 author reply 8-50
17. E.P. Brass, and J.E. Edwards Should the guidelines for management of central venous catheters in patients with candidemia be changed now? Clin Infect Dis 51 2010 304 306
18. D.K. Henderson, J.E. Edwards Jr., and J.Z. Montgomerie Hematogenous candida endophthalmitis in patients receiving parenteral hyperalimentation fluids J Infect Dis 143 1981 655 661
19. L.J. Rodriguez-Adrian, R.T. King, L.G. Tamayo-Derat, J.W. Miller, C.A. Garcia, and J.H. Rex Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiology Medicine (Baltimore) 82 2003 187 202
20. A.M. Oude Lashof, A. Rothova, J.D. Sobel, M. Ruhnke, P.G. Pappas, and C. Viscoli Ocular manifestations of candidemia Clin Infect Dis 53 2011 262 268
21. J.H. Rex, J.E. Bennett, A.M. Sugar, P.G. Pappas, C.M. van der Horst, and J.E. Edwards A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute N Engl J Med 331 1994 1325 1330
22. J.H. Rex, P.G. Pappas, A.W. Karchmer, J. Sobel, J.E. Edwards, and S. Hadley A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects Clin Infect Dis 36 2003 1221 1228
23. A.C. Reboli, C. Rotstein, P.G. Pappas, S.W. Chapman, D.H. Kett, and D. Kumar Anidulafungin versus fluconazole for invasive candidiasis N Engl J Med 356 2007 2472 2482
24. B.J. Kullberg, J.D. Sobel, M. Ruhnke, P.G. Pappas, C. Viscoli, and J.H. Rex Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial Lancet 366 2005 1435 1442
25. J. Mora-Duarte, R. Betts, C. Rotstein, A.L. Colombo, L. Thompson-Moya, and J. Smietana Comparison of caspofungin and amphotericin B for invasive candidiasis N Engl J Med 347 2002 2020 2029
26. E.R. Kuse, P. Chetchotisakd, C.A. da Cunha, M. Ruhnke, C. Barrios, and D. Raghunadharao Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial Lancet 369 2007 1519 1527
27. P.G. Pappas, C.M. Rotstein, R.F. Betts, M. Nucci, D. Talwar, and J.J. De Waele Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis Clin Infect Dis 45 2007 883 893
28. D.H. Kett, A.F. Shorr, A.C. Reboli, A.L. Reisman, P. Biswas, and H.T. Schlamm Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis Crit Care 15 2011 R253
29. M.A. Pfaller, L. Boyken, R.J. Hollis, J. Kroeger, S.A. Messer, and S. Tendolkar In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance J Clin Microbiol 46 2008 150 156
30. S. Grau Cerrato, S. Luque Pardos, and O. Ferrandez Quirante Características farmacocinéticas diferenciales de micafungina. Experiencia en poblaciones especiales Enferm Infecc Microbiol Clin 29 Suppl 2 2011 10 14
31. M.F. Hebert, H.E. Smith, T.C. Marbury, S.K. Swan, W.B. Smith, and R.W. Townsend Pharmacokinetics of micafungin in healthy volunteers, volunteers with moderate liver disease, and volunteers with renal dysfunction J Clin Pharmacol 45 2005 1145 1152
32. C.A. Sable, B.Y. Nguyen, J.A. Chodakewitz, and M.J. DiNubile Safety and tolerability of caspofungin acetate in the treatment of fungal infections Transpl Infect Dis 4 2002 25 30
33. C.O. Morrissey, M.A. Slavin, M.A. O'Reilly, J.R. Daffy, J.F. Seymour, and A.P. Schwarer Caspofungin as salvage monotherapy for invasive aspergillosis in patients with haematological malignancies or following allogeneic stem cell transplantation: efficacy and concomitant cyclosporin A Mycoses 50 Suppl 1 2007 24 37
34. F. Saner, J. Gensicke, P. Rath, N. Fruhauf, Y. Gu, and A. Paul Safety profile of concomitant use of caspofungin and cyclosporine or tacrolimus in liver transplant patients Infection 34 2006 328 332
35. C. Sanz-Rodriguez, R. Arranz, J.M. Cisneros, P.J. Garcia-Sanchez, M. Jurado, and J. Lopez Absence of clinically relevant effect of caspofungin on cyclosporin pharmacokinetics Swiss Med Wkly 135 2005 658 659
36. K.A. Marr, R. Hachem, G. Papanicolaou, J. Somani, J.M. Arduino, and C.J. Lipka Retrospective study of the hepatic safety profile of patients concomitantly treated with caspofungin and cyclosporin A Transpl Infect Dis 6 2004 110 116
37. C. Sanz-Rodriguez, M. Lopez-Duarte, M. Jurado, J. Lopez, R. Arranz, and J.M. Cisneros Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections Bone Marrow Transplant 34 2004 13 20
38. E.J. Anaissie, J.H. Rex, O. Uzun, and S. Vartivarian Predictors of adverse outcome in cancer patients with candidemia Am J Med 104 1998 238 245
39. T.J. Walsh, P. Pappas, D.J. Winston, H.M. Lazarus, F. Petersen, and J. Raffalli Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever N Engl J Med 346 2002 225 234
40. V.V. Moudgal, and J.D. Sobel Antifungal drugs in pregnancy: a review Expert Opin Drug Saf 2 2003 475 483
41. N. de Wet, A. Llanos-Cuentas, J. Suleiman, E. Baraldi, E.F. Krantz, and M. Della Negra A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients Clin Infect Dis 39 2004 842 849
42. H. Dupont, A. Bourichon, C. Paugam-Burtz, J. Mantz, and J.M. Desmonts Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis? Crit Care Med 31 2003 752 757
43. F.C. Riche, X. Dray, M.J. Laisne, J. Mateo, L. Raskine, and M.J. Sanson-Le Pors Factors associated with septic shock and mortality in generalized peritonitis: comparison between community-acquired and postoperative peritonitis Crit Care 13 2009 R99
44. P. Montravers, J.P. Mira, J.P. Gangneux, O. Leroy, and O. Lortholary A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units Clin Microbiol Infect 17 2011 1061 1067
45. A. Roehrborn, L. Thomas, O. Potreck, C. Ebener, C. Ohmann, and P.E. Goretzki The microbiology of postoperative peritonitis Clin Infect Dis 33 2001 1513 1519
46. P. Sandven, H. Qvist, E. Skovlund, and K.E. Giercksky Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations Crit Care Med 30 2002 541 547
47. C. Troppmann, A.C. Gruessner, D.L. Dunn, D.E. Sutherland, and R.W. Gruessner Surgical complications requiring early relaparotomy after pancreas transplantation: a multivariate risk factor and economic impact analysis of the cyclosporine era Ann Surg 227 1998 255 268
48. E. Benedetti, A.C. Gruessner, C. Troppmann, B.E. Papalois, D.E. Sutherland, and D.L. Dunn Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome J Am Coll Surg 183 1996 307 316
49. T. Suzuki, T. Uno, G. Chen, and Y. Ohashi Ocular distribution of intravenously administered micafungin in rabbits J Infect Chemother 14 2008 204 207
50. G.M. Gauthier, T.M. Nork, R. Prince, and D. Andes Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis Clin Infect Dis 41 2005 e27 e28
51. J.C. Sarria, J.C. Bradley, R. Habash, K.T. Mitchell, R.C. Kimbrough, and A.M. Vidal Candida glabrata endophthalmitis treated successfully with caspofungin Clin Infect Dis 40 2005 e46 e48
52. R.F. Betts, M. Nucci, D. Talwar, M. Gareca, F. Queiroz-Telles, and R.J. Bedimo A multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis Clin Infect Dis 48 2009 1676 1684
53. W.J. Steinbach, J.R. Perfect, C.H. Cabell, V.G. Fowler, G.R. Corey, and J.S. Li A meta-analysis of medical versus surgical therapy for Candida endocarditis J Infect 51 2005 230 247
54. D.D. Muehrcke, B.W. Lytle, and D.M. Cosgrove 3rd. Surgical and long-term antifungal therapy for fungal prosthetic valve endocarditis Ann Thorac Surg 60 1995 538 543
55. P.A. Tambyah, and D.G. Maki Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients Arch Intern Med 160 2000 678 682
56. C.A. Kauffman, J.A. Vazquez, J.D. Sobel, H.A. Gallis, D.S. McKinsey, and A.W. Karchmer Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group Clin Infect Dis 30 2000 14 18
57. P.N. Malani, S.A. McNeil, S.F. Bradley, and C.A. Kauffman Candida albicans sternal wound infections: a chronic and recurrent complication of median sternotomy Clin Infect Dis 35 2002 1316 1320
58. I. Palabiyikoglu, E. Tekeli, F. Cokca, O. Akan, N. Unal, and I. Erberktas Nosocomial meningitis in a university hospital between 1993 and 2002 J Hosp Infect 62 2006 94 97
59. M.H. Nguyen, and V.L. Yu Meningitis caused by Candida species: an emerging problem in neurosurgical patients Clin Infect Dis 21 1995 323 327
60. F. Legrand, M. Lecuit, B. Dupont, E. Bellaton, M. Huerre, and P.S. Rohrlich Adjuvant corticosteroid therapy for chronic disseminated candidiasis Clin Infect Dis 46 2008 696 702